Home / Sumatriptan / Czechia
CZ ATC N02CC01 · updated 2 Nov 2026
Sumatriptan shortage in Czechia
Is there a Sumatriptan shortage in Czechia?
Yes. As of 2 Nov 2026, 6 Sumatriptan products are reported short in Czechia, the first since 1 Jul 2026. The company estimate for the return is 13 Nov 2026 (latest 31 May 2027). Main reason: manufacturing problem.
Also short in Canada, Germany, Italy, Spain, Ireland, Austria, Belgium, Norway, Sweden, Japan, New Zealand, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | SUMATRIPTAN VIATRIS 50MG 50MG TBL FLM 6 | VIATRIS LIMITED, Dublin | 1 Jul 2026 | 31 Mar 2027 | Manufacturing problem Výrobní důvody |
| CZ | SUMATRIPTAN ACTAVIS 50MG 50MG TBL OBD 6 I | Teva | 15 Jul 2026 | 31 Jan 2027 | Manufacturing problem Výrobní důvody |
| CZ | IMIGRAN 6MG 6MG INJ SOL ZVL 2X0,5ML+POUZDRO | GlaxoSmithKline Trading Services Limited, Dublin | 3 Sep 2026 | 30 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | ROSEMIG 20MG 20MG NAS SPR SOL 2X0,1ML | GlaxoSmithKline Trading Services Limited, Dublin | 2 Oct 2026 | 17 Dec 2026 | Increased demand Zvýšené prodeje |
| CZ | FRIMIG 50MG 50MG TBL FLM 6 | Orion Corporation, Espoo | 26 Oct 2026 | 13 Nov 2026 | Distribution or logistics Kapacitní/distribuční důvody |
| CZ | SUMATRIPTAN VIATRIS 100MG 100MG TBL FLM 2 | VIATRIS LIMITED, Dublin | 1 Nov 2026 | 31 May 2027 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.